Liuska M. Pesce, MD, Program Chair (2020-present)
Clinical Professor
Pediatric Thyroid Clinic Director
Stead Family Department of Pediatrics
Division of Pediatric Endocrinology and Diabetes
University of Iowa Carver College of Medicine
Li Chan, MD
Reader in Molecular Endocrinology and Metabolism
Honorary Consultant in Paediatric Endocrinology
Centre for Endocrinology
William Harvey Research Institute
Cem S. Demirci, MD
Pediatric Endocrinology
Director, Type 1 Diabetes Program
Connecticut Children’s Medical Center
Oscar Escobar, MD
Associate Professor
University of Pittsburgh School of Medicine
UPMC Children's Hospital of Pittsburgh
Reema L. Habiby, MD
Associate Professor of Pediatrics
Northwestern University Feinberg School of Medicine
Ann & Robert H. Lurie Children’s Hospital of Chicago
Shana McCormack, MD
Assistant Professor of Pediatrics
Children's Hospital of Philadelphia
Ryan S. Miller, MD
Associate Professor
University of Maryland School of Medicine
Ron Newfield, MD
Clinical Professor
University of California – San Diego
Rady Children’s Hospital San Diego
Siobhan Pittock, MD
Pediatric Endocrinologist
Mayo Clinic
Sripriya Raman, MD
Pediatric Endocrinologist
K S Pediatrics
Christine M. Trapp, MD
Pediatric Endocrinology, Connecticut Children's Medical Center
Associate Fellowship Director, Pediatric Endocrinology
Assistant Professor of Pediatrics
University of Connecticut School of Medicine
Halley Wasserman, MD
Assistant Professor
Cincinnati Children's Hospital Medical Center
Ari Wassner, MD
Medical Director, Thyroid Center
Director, Endocrinology Fellowship Training Program
Associate Professor of Pediatrics
Boston Children's Hospital
Harvard Medical School
Abbie L. Young, MS, CGC, ELS(D)
Medical Editor
STATEMENT OF INDEPENDENCE
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s P-ESAP Faculty Working Group.
DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (eg, stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers’ bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivering content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.
The following faculty reported relevant financial relationship(s): Li Chan, MD, is an advisory board member of OMass Therapeutics and Great Ormond Street Hospital Children’s Charity Research. Oscar Escobar, MD, is a board member of the Human Growth Foundation. He is a primary
investigator in industry-supported multicentric study for Pfizer, OPKO, and Novo Nordisk. Shana McCormack, MD, is an NIH grantee and grant reviewer. She is a grantee of the Doris Duke Charitable Foundation and the Friedreich Ataxia Research Alliance. She is a consultant for Rhythm Pharmaceuticals and Reata Pharmaceuticals. Ryan S. Miller, MD, is an NIH grantee. Ron Newfield, MD, is a principal investigator for Spruce and Neurocrine for new medications; a consultant for Spruce; a consultant and member of the Independent Safety Committee for Ascendis; a principal investigator for Merck; and a principal investigator for Zealand for dasiglucagon. Ari Wassner, MD, is a topic peer reviewer for UpToDate (thyroid).
The following committee members reported no relevant financial relationships:
Cem S. Demirci, MD; Reema L. Habiby, MD; Liuska M. Pesce, MD; Siobhan Pittock, MD; Sripriya Raman, MD; Christine M. Trapp, MD; Halley Wasserman, MD.
The medical editor for this program, Abbie L. Young, MS, CGC, ELS(D), reported no relevant financial relationships.
The Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.
The Endocrine Society staff have reviewed all disclosures and resolved or managed all relevant identified conflicts of interest, as applicable.
ACKNOWLEDGMENT OF COMMERCIAL SUPPORT
This activity is not supported by educational grant(s) or other funds from any commercial supporter.